[1]
Breccia, M. et al. 2011. LOW INCIDENCE RATE OF OPPORTUNISTIC AND VIRAL INFECTIONS DURING IMATINIB TREATMENT IN CHRONIC MYELOID LEUKEMIA PATIENTS IN EARLY AND LATE CHRONIC PHASE. Mediterranean Journal of Hematology and Infectious Diseases. 3, 1 (May 2011), e2011021. DOI:https://doi.org/10.4084/mjhid.2011.021.